approval · primary record
MARALIXIBAT CHLORIDE
2 approval events · latest 2025-04-10
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-04-10 |
| Approval events | 2 |
| Brand | LIVMARLI |
| Sponsor | MIRUM |
| Route | ORAL |
Approval history
2 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-04-10 | FDA | NDA | LIVMARLI | MIRUM | ORAL |
| 2024-11-08 | FDA | NDA | LIVMARLI | MIRUM | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:31:20.880Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:maralixibat-chloride
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Maralixibat Chloride · compound